sur EUROAPI (isin : FR0014008VX5)
EUROAPI secures financing for its FOCUS-27 plan
EUROAPI has finalized the financing of its FOCUS-27 strategic plan with several financial initiatives. The company has refinanced a €451 million revolving credit facility, extending its maturity to February 2029. This refinancing, bearing interest indexed to EURIBOR, includes clauses on the leverage ratio and liquidity.
Sanofi has subscribed to a €200 million super-subordinated hybrid bond to support the FOCUS-27 plan, providing EUROAPI with increased financial flexibility. The bond carries a coupon of 8.113% until 2029.
A €54 million agreement with Sanofi will allow for capacity reservations for five products, improving revenues and performance. Amendments to the manufacturing contract are planned, including guaranteed volumes for Sevelamer.
R. H.
Copyright © 2024 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de EUROAPI